ASLAN Pharmaceuticals Ltd. announced today announced that it has entered into a definitive agreement for the purchase and sale of 5,000,000 of the Company’s American Depositary Shares, each ADS representing twenty-five ordinary shares, at an offering price of $1.00 per ADS in a registered direct offering.
March 12, 2024
· 6 min read